Main

COLAZAL(R) Pediatric Exclusivity Filing Submitted (Business Wire via Yahoo! Finance)


COLAZAL(R) Pediatric Exclusivity Filing Submitted (Business Wire via Yahoo! Finance)
RALEIGH, N.C.----July 5, 2006--Salix Pharmaceuticals, Ltd. today announced that the Company submitted on June 20, 2006 what it believes to be a complete response to a Written Request received from the U.S.

Salix Expands XIFAXAN(R) Intellectual Property (Business Wire via Yahoo! Finance)
RALEIGH, N.C.----July 5, 2006--Salix Pharmaceuticals, Ltd. today announced that the Company has entered into an agreement with Cedars-Sinai Medical Center, or CSMC, for the right to use U.S.

CSMC grants rights over rifaximin to Salix (PharmaBiz)
Salix Pharmaceuticals, Ltd. announced that the company has entered into an agreement with Cedars-Sinai Medical Center, (CSMC), for the right to use US Patent No. 6,861,053 and US Patent Application No. 11/234,516 relating to methods of diagnosis and treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth.

GlaxoSmithKline Gets Added Avandamet OK (AP via Yahoo! Finance) British


GlaxoSmithKline Gets Added Avandamet OK (AP via Yahoo! Finance)
British drug maker GlaxoSmithKline PLC said Tuesday that the Food and Drug Administration approved one of its diabetes drugs for use as a front-line treatment.

FDA approves GSK diabetes drug as initial treatment (Pittsburgh Business Times)
The U.S. Food and Drug Administration on Tuesday granted approval for GlaxoSmithKline to sell its diabetes drug Avandamet as a first line of defense against the disease.
 
Notify me with the latest breaking FDA News
fda approvals Tell us where to send your notifications:

Diabetes treatments may help Alzheimers - meeting (Reuters via Yahoo!


Diabetes treatments may help Alzheimers - meeting (Reuters via Yahoo! News)
Diabetes and pre-diabetic conditions appear to worsen the risk of Alzheimer's disease but drugs that help regulate blood sugar may help patients with dementia as well, researchers report.

GlaxoSmithKline Gets Added Avandamet OK (AP via Yahoo! Finance)
British drug maker GlaxoSmithKline PLC said Tuesday that the Food and Drug Administration approved one of its diabetes drugs for use as a front-line treatment.

GlaxoSmithKline Announces FDA Approval And The Launch Of Avandamet(R) (Rosiglitazone Maleate And Metformin HCl) In The (Medical News Today)
GlaxoSmithKline announced todayFDA approval of Avandamet(R) (rosiglitazone maleate and metformin HCl) foruse as initial treatment of type 2 diabetes as an adjunct to diet andexercise. Avandamet was previously approved as a second-line therapy -- itwas indicated for use in patients who were uncontrolled on metforminmonotherapy. [click link for full article]

 

©2006 FDA-News.com. All rights reserved.